Assessment of a new treatment schedule in sublingual immunotherapy.: A randomised double-blind placebo-controlled multicentre study

被引:3
|
作者
Boquete, M
Rodriguez, F
Tabar, A
Ibañez, D
Nieto, A
Torre-Martinez, F
机构
[1] Hosp Xeral Calde, Lugo, Spain
[2] Hosp Marques Valdecilla, Santander, Spain
[3] Hosp Virgen Del Camino, Pamplona, Spain
[4] Hosp Nino Jesus, Madrid, Spain
[5] Hosp La Fe, Valencia, Spain
[6] ALK ABELLO SA, Madrid, Spain
关键词
D O I
10.1016/j.jaci.2005.12.646
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
631
引用
收藏
页码:S162 / S162
页数:1
相关论文
共 50 条
  • [31] Sublingual immunotherapy for hay fever: a 2-year double-blind placebo-controlled trial
    Smith, HE
    White, PJ
    Poole, J
    Annila, I
    Andre, C
    Frew, AJ
    ALLERGY, 2002, 57 : 31 - 31
  • [32] Acupressure treatment of morning sickness in pregnancy -: A randomised, double-blind, placebo-controlled study
    Norheim, AJ
    Pedersen, EJ
    Fonnebo, V
    Berge, L
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2001, 19 (01) : 43 - 47
  • [33] Double-blind, randomised, placebo-controlled study of leflunomide in the treatment of active ankylosing spondylitis
    Van Denderen, JC
    Van der Paardt, M
    Nurmohamed, MT
    De Ryck, YM
    Dijkmans, BAC
    Van der Horst-Bruinsma, IE
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 397 - 397
  • [34] Magnetic pulse treatment for knee osteoarthritis: A randomised, double-blind, placebo-controlled study
    Pipitone, N
    Scott, DL
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 17 (03) : 190 - 196
  • [35] Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial (CoFAR)
    Fleischer, D. M.
    Wood, R. A.
    Jones, S. M.
    Sicherer, S. H.
    Liu, A. H.
    Stablein, D.
    Henning, A.
    Mayer, L.
    Lindblad, R.
    Sampson, H. A.
    Burks, A. W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB66 - AB66
  • [36] Sublingual immunotherapy for hazelnut food allergy:: A randomized, double-blind, placebo-controlled study with a standardized hazelnut extract
    Enrique, E
    Pineda, F
    Malek, T
    Bartra, J
    Basagaña, M
    Tella, R
    Castelló, JV
    Alonso, R
    de Mateo, JA
    Cerdá-Trias, T
    Miguel-Moncín, MDM
    Monzón, S
    García, M
    Palacios, R
    Cisteró-Bahíma, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) : 1073 - 1079
  • [37] House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis
    Bozek, A.
    Ignasiak, B.
    Filipowska, B.
    Jarzab, J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (02): : 242 - 248
  • [38] Reduction of oral corticotherapy by sublingual immunotherapy (IT): Double-blind placebo-controlled study in grass pollen allergy.
    Clavel, R
    Andre, C
    Bousquet, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 197 - 197
  • [39] LongoVital® and herpes labialis:: a randomised, double-blind, placebo-controlled study
    Pedersen, A
    ORAL DISEASES, 2001, 7 (04) : 221 - 225
  • [40] Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo-controlled study
    Pajno, Giovanni B.
    Caminiti, Lucia
    Vita, Daniela
    Barberio, Giovanni
    Salzano, Giuseppina
    Lombardo, Fortunato
    Canonica, Giorgio Walter
    Passalacqua, Giovanni
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (01) : 164 - 170